BLEEDnFIRE Therapeutics AG

The company aims to develop, manufacture, market, and distribute therapeutics for the treatment of patients with life-altering hematological and inflammatory diseases. The company may establish branches and subsidiaries, both domestically and abroad, participate in other enterprises of any kind, assume representations, and enter into any transactions and conclude contracts that may be suitable to promote the company's purpose or are directly or indirectly related thereto. It may also grant loans on its own or another's account, as well as provide guarantees, sureties, and pledge transactions for affiliated enterprises and third parties. The company may acquire, lease, rent, manage, encumber, and dispose of real estate, both domestically and abroad. The company may acquire, hold, manage, or sell any type of debt or securities, within Switzerland or abroad.